BP Measurement in the SBP Intervention Trial
Dr. Karen Johnson and Dr. C. Michael Gibson Discuss... Read more.
Continued versus Interrupted NOAC at the time of Device Surgery
Dr. David Birnie and Dr. C. Michael Gibson Discuss... Read more.
Critical Analysis from the CANTOS Trial
Dr. Paul Ridker and Dr. C. Michael Gibson Discuss: CANTOS – Residual Inflammatory Risk and Residual Cholesterol Risk... Read more.
Does High-Intensity Pitavastatin Therapy Improve Clinical Outcomes?
Dr. Takeshi Kimura and Dr. C. Michael Gibson Discuss REAL-CAD – Does High-Intensity Pitavastatin Therapy Further Improve Clinical Outcomes?... Read more.
FOURIER – Evolocumab and Outcomes in PAD
Dr. Marc Bonaca and Dr. C. Michael Gibson Discuss... Read more.
ESC 2017 Wrap-Up from a Pacific Rim Perspective
Dr. Philip Aylward and Dr. Chris Hammett Present... Read more.
ESC 2017 Wrap-Up in Romanian
Dr. Dragos Vinereanu and Dr. Dan Gaita Present... Read more.
Does intensive statin lowering therapy in diabetic retinopathy reduce CV events?
Dr. Hiroshi Itoh and Dr. Rim Halaby discuss... Read more.
ESC 2017 Wrap-Up in French
Dr. Gilles Montalescot and Dr. Mathieu Kerneis Present... Read more.
ESC 2017 Wrap-Up from a Scandinavian Perspective
Dr. Jonas Oldgren, Dr. Stephen James and Dr. Robin Hofmann Present... Read more.